Investigational Pneumococcal
Vaccine Study

Now Open in Savannah

About This Research Study

Pneumococcal disease, caused by a type of bacterium called Streptococcus pneumoniae, is one of the largest vaccine-preventable causes of death in children and older adults worldwide. While pneumococcal vaccines are given to children regularly, adults — particularly seniors — are still at risk of serious illness from the disease due to low rates of vaccination.

Meridian is now enrolling adults for a study of an investigational vaccine that may provide protection against pneumococcal disease.

Eligible participants…

  • Must be age 18 to 50 or 60 to 75
  • Must NOT have regularly used tobacco or nicotine-containing products within 6 months prior to screening
  • Must NOT have a history of confirmed pneumococcal infection within the past 12 months
  • Will receive either an investigational pneumococcal vaccine or placebo
  • Will receive compensation for study-related time
  • Do not need insurance to join this study

For more information, complete the form on this page. After you submit your information, a Meridian enrollment specialist will call you to talk about the study. There is no obligation to participate — you can decide if the study is right for you.

You can also talk to a Meridian enrollment specialist about this study by calling (912) 623-2240.

Expect Excellence icon - supporting research since 1999

Submit your information

Study Locations


  • Savannah: Meridian Clinical Research, 340 Eisenhower Dr #1500, Savannah, GA 31406

Founded in 1999 in Omaha, NE, Meridian studies the safety and effectiveness of new medicines, devices, and treatments. Its mission is to enrich lives by providing quality, compassionate care to patients and unparalleled clinical research services. Clinical studies help scientists develop life-changing medicines, but it starts with you — participation makes it all possible. For more than 20 years, thousands of patients have trusted Meridian because of our focus on creating a positive patient experience.